A multicentre randomised phase II trial of gemcitabine alone vs gemcitabine and S-1 combination therapy in advanced pancreatic cancer: GEMSAP study - Concepedia

Concepedia

Publication | Open Access

A multicentre randomised phase II trial of gemcitabine alone vs gemcitabine and S-1 combination therapy in advanced pancreatic cancer: GEMSAP study

DOI Full Paper Access

104

Citations

23

References

2012

Year

Yousuke Nakai, Hiroyuki Isayama, Takashi Sasaki, Naoki Sasahira, Takuya Tsujino, Nobuo Toda, Hirofumi Kogure, Saburo Matsubara, Yukiko Ito, Osamu Togawa,

British Journal of Cancer

Abstract

Gemcitabine and S-1 combination therapy demonstrated longer PFS in advanced pancreatic cancer. Improved OS duration of 4.7 months was found for gemcitabine and S-1 combination therapy, though this was not statistically significant.

References

	Year	Citations

Page 1